中医临床研究
中醫臨床研究
중의림상연구
CLINICAL JOURNAL OF CHINESE MEDICINE
2013年
17期
19-20
,共2页
胃肠肿瘤术后化疗%腹泻%参苓白术散%培菲康
胃腸腫瘤術後化療%腹瀉%參苓白術散%培菲康
위장종류술후화료%복사%삼령백술산%배비강
Gastrointestinal tumor postoperative chemotherapy%Diarrhea%Shenling Baizhu powder%Bifico capsule
目的：探讨参苓白术散联合培菲康治疗胃肠肿瘤术后化疗所致腹泻的临床疗效。方法：选取本院及广东省农垦中心医院2008～2011年收治、化疗后发生腹泻的胃肠肿瘤术后患者88例，随机分为三组，对照组29例采用常规西药治疗，中药组29例采用参苓白术散辨证治疗，联合组30例在中药组的基础上加用培菲康；比较三组药物的临床有效率和各组患者治前后症状、体征改善率。结果：对照组、中药组、联合组三组药物的临床有效率分别为69%、79.3%、93.3%；对照组、中药组、联合组三组患者的临床症状、体征改善率分别为：56.5%、66.3%、93.4%；各评价指标均为依次升高，且组与组之间差异显著（P<0.05）。结论：参苓白术散联合培菲康治疗胃肠肿瘤术后化疗所致腹泻可显著改善患者临床症状、体征，临床疗效显著，具有较高的临床推广价值。
目的：探討參苓白術散聯閤培菲康治療胃腸腫瘤術後化療所緻腹瀉的臨床療效。方法：選取本院及廣東省農墾中心醫院2008～2011年收治、化療後髮生腹瀉的胃腸腫瘤術後患者88例，隨機分為三組，對照組29例採用常規西藥治療，中藥組29例採用參苓白術散辨證治療，聯閤組30例在中藥組的基礎上加用培菲康；比較三組藥物的臨床有效率和各組患者治前後癥狀、體徵改善率。結果：對照組、中藥組、聯閤組三組藥物的臨床有效率分彆為69%、79.3%、93.3%；對照組、中藥組、聯閤組三組患者的臨床癥狀、體徵改善率分彆為：56.5%、66.3%、93.4%；各評價指標均為依次升高，且組與組之間差異顯著（P<0.05）。結論：參苓白術散聯閤培菲康治療胃腸腫瘤術後化療所緻腹瀉可顯著改善患者臨床癥狀、體徵，臨床療效顯著，具有較高的臨床推廣價值。
목적：탐토삼령백술산연합배비강치료위장종류술후화료소치복사적림상료효。방법：선취본원급광동성농은중심의원2008～2011년수치、화료후발생복사적위장종류술후환자88례，수궤분위삼조，대조조29례채용상규서약치료，중약조29례채용삼령백술산변증치료，연합조30례재중약조적기출상가용배비강；비교삼조약물적림상유효솔화각조환자치전후증상、체정개선솔。결과：대조조、중약조、연합조삼조약물적림상유효솔분별위69%、79.3%、93.3%；대조조、중약조、연합조삼조환자적림상증상、체정개선솔분별위：56.5%、66.3%、93.4%；각평개지표균위의차승고，차조여조지간차이현저（P<0.05）。결론：삼령백술산연합배비강치료위장종류술후화료소치복사가현저개선환자림상증상、체정，림상료효현저，구유교고적림상추엄개치。
Objective:To investigate the clinical effect of gastrointestinal tumor after chemotherapy induceddiarrhea by Shenling Baizhu powder combined with Bifico. Methods:88 cases with diarrhea induced by gastrointestinal tumor postoperative chemotherapy were chosen and randomly divided into three groups;29 patients of control group were treated with routine modern medicine, and 29 patients of Chinese medicine group were treated with with Shenling Baizhu powder, while 30 cases of joint group were treated with Bifico capsule on the basis of Shenling Baizhu powder;The clinical efficient and patient symptom recovery rate were compared between each other after cure period. Results:The medicine clinical effective rate of the control group, Chinese medicine group, and joint group was 69%, 79.3%, and 93.3%respectively;And the patient symptom recovery rate of the control group, Chinese medicine group, joint group was 56.5%, 66.3%, 93.4%respectively;In order of above groups, each index was in a increasing trend and significantly different between group and group (P<0.05). Conclusion: Shenling Baizhu powder combined with Bifico can significantly improve the patient symptom recovery rate and clinical curative effect which has a high clinical value for the diarrhea caused by gastrointestinal tumor postoperative chemotherapy.
